On 14 September 2015, the Court of Appeal of Mons permitted parallel imported pharmaceutical products to be repackaged and sold in package sizes that are predominant on the Belgian market.

Food law is extensively harmonized throughout the EU, but national law still has a role to play. In this short article, we look at three developments in Belgian food law that have taken place in 2023...

The European Commission has opened the floor for a discussion on whether the EU medical devices legislation is effective, efficient, relevant, coherent and valuable.

Shrinkflation is a commercial practice which consists of reducing the size of a product while maintaining or even increasing its price. With the increases in raw materials costs.

With formal adoption by both the Council of the EU and the EU Parliament expected by summer 2026, stakeholders should start looking into implementation preparations...

In reaching this conclusion, the Court referred to the Belgian regulatory framework which embraces the principle of "therapeutic freedom" which, as a rule, prohibits substitution in the deliverance of medicines.

On 29 March 2019 the U.S. Food and Drug Administration's (FDA) Office of Regulatory Affairs issued a draft guidance document titled "Review and Update of Device Establishment Inspection

FDA recently released a Draft Guidance for Industry entitled, "Reducing Microbial Food Safety Hazards in the Production of Seed for Sprouting" ("Draft Guidance"). The Draft Guidance

The Court of Justice of the European Union issued a judgment interpreting the Specific Mechanism for parallel importation of pharmaceutical products from new EU Member States shortly after their accession to the EU.

On July 27, 2004, the European Parliament Committee for Environment, Public Health and Food Safety (ENVI COM) will hold its first meeting under the sixth Parliamentary Term.

On 28 February, the High Court handed down an interim judgment in Eli Lilly v Neopharma and Anor (Howrey acting for Eli Lilly) in which it ordered the disclosure of information relating to sales of the (allegedly) infringing pharmaceutical Olanzapine Neopharma.

Convinced that these practices infringed its copyright in the taste of "Heksenkaas", Levola brought an action against Smilde for copyright infringement.

On 6 December 2012, the Court of Justice of the European Union handed down its judgment in the AstraZeneca case, following an appeal against a 2010 judgment of the General Court which itself had upheld in large part an earlier decision of the European Commission that had imposed a € 60 million fine on the company for abuse of the patent system and regulatory procedures in the pharmaceutical sector.

On 21 September 2023, the EU Court of Justice (‘CJEU') handed down its ruling in the Apotheke B. case (C-47/22), and it is a good example of the high threshold set by the EU Court of Justice...

The Veterinary Medicinal Products Regulation (EU) 2019/6 has applied in the EU since 28 January 2022, replacing Directive 2001/82/EC. The new rules on good manufacturing practice (GMP) will in turn...

On 22 July 2025, the European Commission adopted Implementing Regulation (EU) 2025/1466 ("Regulation"), updating the EU pharmacovigilance (or "PV") rules by way of amendments...

On 21 March 2024, the EU Court of Justice (‘CJEU') handed down its ruling in case C‑7/23, concerning a dispute between a feed company, Marvesa Rotterdam NV, and the Federal Agency...

Belgium introduces significant reforms to pharmaceutical law through the Act of 30 May 2026, addressing critical medicine shortages through enhanced export controls and stock allocation measures. The legislation also modernizes the Federal Agency for Medicines and Health Products' operational framework and adapts clinical trial regulations to support decentralized research models.

On 13 December 2019, the European Medicines Agency ("EMA") published a Questions and Answers document ("Q&A")

On 21 February 2025, the EU Commission adopted Regulation (EU) 2025/351, the so-called 19th Amendment to the Plastics Regulation (Regulation (EU) No 10/2011)...